HomeProductsBuilding BlocksCarbocyclic ScaffoldsBenzene CompoundsMetoprolol
Chemical structure of CAS 51384-51-1

Metoprolol

In Stock•Starting at $45 for 50 mg•Purity ≥ 97%
CAS No.51384-51-1
MDL No.MFCD00599534
MFC15H25NO3
MW267.36
InChI KeyIUBSYMUCCVWXPE-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
50 mg97%$45In Stock
250 mg97%$152In Stock
1 g97%$430In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Metoprolol is a propanolamine with the structure 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group. It functions as a beta-adrenergic antagonist, antihypertensive agent, xenobiotic, environmental contaminant, and geroprotector. It is classified as a propanolamine, aromatic ether, secondary alcohol, and secondary amino compound.

CAS No.51384-51-1
Product NameMetoprolol

Biological Targets

ADRB1

Associated Conditions

Ventricular arrhythmia·congenital mitral valve insufficiency·ST Elevation Myocardial Infarction·angina pectoris·vascular disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences • Vol. 12, Issue 3 • 2001
PMID: 11113639DOI: 10.1016/s0928-0987(00)00117-2

Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.

European heart journal • Vol. 22, Issue 1 • 2001
PMID: 11133211DOI: 10.1053/euhj.1999.2006

Oxygen consumption in patients with hyperthyroidism before and after treatment with beta-blockade versus thyrostatic treatment: a prospective randomized study.

Annals of surgery • Vol. 233, Issue 1 • 2001
PMID: 11141226PMC: PMC1421167DOI: 10.1097/00000658-200101000-00010

Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial.

Journal of cardiovascular pharmacology • Vol. 37, Issue 1 • 2001
PMID: 11152373DOI: 10.1097/00005344-200101000-00006

Documentation

Similar Products